Mediators and mechanisms of acute lung injury (Q34053379)

30 July 2017

1 reference

title

Mediators and mechanisms of acute lung injury (English)

1 reference

30 July 2017

1 reference

Parsons PE

1

1 reference

30 July 2017

1 September 2000

1 reference

Clinics in Chest Medicine

30 July 2017

1 reference

30 July 2017

21

1 reference

30 July 2017

3

1 reference

30 July 2017

467-476

1 reference

Relative production of tumour necrosis factor alpha and interleukin 10 in adult respiratory distress syndrome

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Adherence to endothelial cells induces release of soluble tumor necrosis factor (TNF) receptor forms from neutrophil granulocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

The role of nuclear factor-kappa B in cytokine gene regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

The pathogenesis of sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Plasma tumor necrosis factor levels in patients with presumed sepsis. Results in those treated with antilipid A antibody vs placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Identification of a homozygous missense mutation (Arg to Gly) in the critical binding region of the human EC-SOD gene (SOD3) and its association with dramatically increased serum enzyme levels

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease. Different syndromes?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

For whom the bell tolls

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. The Sepsis Intervention Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Interleukin-1 receptor antagonist gene polymorphism in Japanese patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Tumor Necrosis Factor Levels in Serum and Bronchoalveolar Lavage Fluid of Patients with the Adult Respiratory Distress Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Elevated interleukin-1 release by human alveolar macrophages during the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Interleukin 8 (IL-8) in the bronchoalveolar lavage fluid from patients with the adult respiratory distress syndrome (ARDS) and patients at risk for ARDS

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Association of pulmonary surfactant protein A (SP-A) gene and respiratory distress syndrome: interaction with SP-B.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Variable airway responsiveness to inhaled lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Circulating interleukin-1 receptor antagonist concentrations are increased in adult patients with thermal injury

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Tumour necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Increased interleukin-8 concentrations in the pulmonary edema fluid of patients with acute respiratory distress syndrome from sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

The toll of innate immunity on microbial pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Endotoxin-stimulated human monocyte secretion of interleukin 1, tumour necrosis factor alpha, and prostaglandin E2 shows stable interindividual differences.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

The role of chronic alcohol abuse in the development of acute respiratory distress syndrome in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Endothelial cell activity varies in patients at risk for the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Early detection and markers of sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Studies on the role of tumor necrosis factor in adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Circulating IL-1ra and IL-10 levels are increased but do not predict the development of acute respiratory distress syndrome in at-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Serum Cytokine Levels in Human Septic Shock

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Biological markers of acute lung injury: prognostic and pathogenetic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's di

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Immunoreactive interleukin-1 in bronchoalveolar lavage fluid of high-risk patients and patients with the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Racial differences in allelic distribution at the human pulmonary surfactant protein B gene locus (SP-B).

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Genetic influence on cytokine production and fatal meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Molecular analysis of extracellular-superoxide dismutase gene associated with high level in serum

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970159-3

7 January 2021

10.1016/S0272-5231(05)70159-3

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

11019720